EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 24 filers reported holding EVOKE PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 32,000 | $113,000 | 0.09% |
| Cetera Advisor Networks LLC | 30,260 | $107,000 | 0.00% |
| Creative Planning | 100,000 | $354,000 | 0.00% |
| OPTIMUM INVESTMENT ADVISORS | 800 | $3,000 | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 37,438 | $133,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 188,514 | $667,000 | 0.00% |
| CITIGROUP INC | 500 | $2,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 35,174 | $125,000 | 0.00% |